Clinical Trials
4 trialsNCT06319313 2024-03-20
Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc.
Phase 2/3 Not yet recruiting
NCT01642004 2022-12-28
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
Bristol-Myers Squibb
Phase 3 Completed
NCT05429463 2022-12-14
neoSCORE â…¡
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Recruiting
NCT01721759 2022-06-28
Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens
Bristol-Myers Squibb
Phase 2 Completed